SCHEMBL7404359

SCHEMBL7404359

Nc1ccccc1OCCN1CCC(Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
TMEM97 Q5BJF2 2/20 0.56
SIGMAR1 Q99720 2/20 0.56
NPSR1 Q6W5P4 1/20 0.55
DRD4 P21917 3/20 0.51
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
PRMT3 O60678 1/20 0.48
CARM1 Q86X55 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
PRMT1 Q99873 1/20 0.48
PRMT8 Q9NR22 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7402428 0.91 KDM4E (0.55) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7398178 0.90 TMEM97 (0.69) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL6208540 0.84 DRD4 (0.70) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7406605 0.83 SIGMAR1 (0.82) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7403447 0.82 TMEM97 (0.64) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL7409008 0.81 SIGMAR1 (0.80) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7403057 0.81 KDM4E (0.61) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7404898 0.81 SIGMAR1 (0.62) ALDH1A1TMEM97SIGMAR1DRD4HRH3
SCHEMBL7409069 0.80 SIGMAR1 (0.82) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7403112 0.80 SIGMAR1 (0.55) KDM4EMEN1KMT2AALDH1A1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed